Ariad Pharmaceuticals Inc fka ARIA

[JDUser1963]

Big Pharma Offer Due to FDA 6 Month Safety Eval, so look at the clinical adverse event evals on the site, none reported. That means the FDA will likely now grant an expanded use study or two to move forward with an accelerated status. If there is any time to buy this drug it is now, to wait will be foolish as Arias will like enter a P-Ship and the stock will triple based on fat funding. That would not be smart, especially while the PPS is so low and now the drug has been proven not only efficient but safe as well with the labeling. Watch this one for buyout.